Sep 29, 2025 03:08PM
Sep 29, 2025 03:08PM
Aug 14, 2025 04:10PM
Jun 30, 2025 09:02AM
Jun 30, 2025 09:00AM
Jun 17, 2025 04:10PM
Jun 17, 2025 04:10PM Applied DNA Announces Retirement of Chairperson and CEO Dr. James A. Hayward
May 15, 2025 04:05PM
Feb 13, 2025 04:03PM
Sep 4, 2024 09:04AM
Sep 4, 2024 09:00AM
Aug 8, 2024 04:10PM
Aug 7, 2024 08:00AM
Jul 29, 2024 11:57AM CORRECTING AND REPLACING: Applied DNA to Showcase Linea IVT as a High-yield, dsRNA-Mitigated Platform for the GMP Manufacture of RNA at the 4th Annual mRNA-based Therapeutics Summit
Jul 29, 2024 11:10AM
Jul 25, 2024 09:11AM
Jul 25, 2024 09:00AM
Jul 18, 2024 10:05AM
Jul 18, 2024 10:00AM
Jun 20, 2024 09:18AM
Jun 20, 2024 09:15AM Applied DNA and Alphazyme Conclude Linea(TM) RNAP Manufacturing Scale-up Project, Deliver Substantial Improvement in Linea(TM) IVT Platform Economics
Jun 18, 2024 10:38AM
Jun 18, 2024 09:04AM
Jun 18, 2024 09:00AM
Jun 18, 2024 09:00AM
Jun 13, 2024 09:03AM
Jun 13, 2024 09:00AM
Jun 5, 2024 09:03AM Applied DNA Sciences (APDN) Receives Notice of Allowance for U.S. Patent Covering Fundamental Aspect of its Linea IVT Platform
Jun 5, 2024 09:00AM
May 28, 2024 09:32AM
May 28, 2024 09:30AM
May 13, 2024 08:55AM
May 10, 2024 04:05PM
May 10, 2024 09:23AM
May 10, 2024 09:00AM Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement
Apr 25, 2024 09:32AM
Apr 25, 2024 09:31AM
Apr 25, 2024 09:00AM
Apr 25, 2024 09:00AM
Apr 22, 2024 04:07PM
Apr 22, 2024 04:05PM
Mar 18, 2024 09:03AM Applied DNA Sciences (APDN) Enters into Agreement with Alphazyme for Scale-Up Manufacturing of its Proprietary Linea RNAP
Mar 18, 2024 09:00AM
Mar 14, 2024 10:00AM
Feb 8, 2024 04:05PM
Feb 5, 2024 01:00PM
Feb 2, 2024 04:15PM
Jan 31, 2024 08:01AM
Jan 31, 2024 08:00AM Applied DNA Announces $3.44 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Dec 14, 2023 08:01AM

1,157,716 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All